Hideyuki Nakagawa

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

Tomoya Kawaguchi, Masahiko Ando, Kazuhiro Asami et al. · Journal of Clinical Oncology · 2014 · 261 citations · Full text

Bronchioloalveolar carcinoma arising in a bronchogenic cyst

Chiaki Endo, Tadashi Imai, Hideyuki Nakagawa et al. · The Annals of Thoracic Surgery · 2000 · 87 citations

Histopathology, Pathology, Bronchioloalveolar Carcinoma +3

Demonstration of a Homogeneous Noncompetitive Immunoassay Based on Bioluminescence Resonance Energy Transfer

Ryoichi Arai, Hideyuki Nakagawa, Kouhei Tsumoto et al. · Analytical Biochemistry · 2001 · 74 citations

Engineering, Bioluminescence, Excitation Energy Transfer +5

Detection of Protein–Protein Interaction by Bioluminescence Resonance Energy Transfer from Firefly Luciferase to Red Fluorescent Protein

Ryoichi Arai, Hideyuki Nakagawa, Atsushi Kitayama et al. · Journal of Bioscience and Bioengineering · 2002 · 53 citations

Protein Chemistry, Protein–protein Interaction, Bioluminescence +9

Detection of protein-protein interaction by bioluminescence resonance energy transfer from firefly luciferase to red fluorescent protein

Ryoichi Arai, Hideyuki Nakagawa, Atsushi Kitayama et al. · Journal of Bioscience and Bioengineering · 2002 · 46 citations

Protein Chemistry, Bioluminescence, Firefly Luciferase +9